Page 20 - Managed Care News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Experts delve into the fundamentals of gene therapy, covering in vivo and ex vivo methods, and explore cellular function targets for effective treatment of a disease.

Jessica Nance, MD, MS, discusses maximizing gene therapy efficiency by selecting vectors for gene size, tissue targeting, and low exposure, and focusing on precise promoters for expression.

Mutual of America Capital Management LLC lessened its stake in Centene Co. (NYSE:CNC – Free Report) by 3.1% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 96,441 shares of the company’s stock after selling 3,068 shares during the quarter. Mutual of America Capital […]

Artisan Partners Limited Partnership cut its stake in Centene Co. (NYSE:CNC – Free Report) by 3.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 899,297 shares of the company’s stock after selling 32,086 shares during the period. Artisan Partners Limited […]

Artisan Partners Limited Partnership trimmed its holdings in Centene Co. (NYSE:CNC – Free Report) by 3.4% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 899,297 shares of the company’s stock after selling 32,086 shares during the period. Artisan Partners Limited Partnership’s holdings in Centene were worth $61,944,000 as of its most recent […]